Results: The study groups included 308 controls (no AKI-RI or failure), 161 with AKI-RI, and 89 with failure. Young age, preoperative need for mechanical ventilation, milrinone, or gentamicin; intraoperative use of milrinone and furosemide; durations of CPB and anesthesia; multiple cross-clamp and transfusion of blood products were significantly associated with AKI or failure. Young age, perioperative use of milrinone, multiple cross-clamps, extracorporeal GSK1210151A membrane oxygenation, cardiac failure, neurological complications, sepsis, and failure significantly increased the

odds of mortality.

Conclusion: This study identified multiple perioperative risk factors for AKI-RI, failure, and mortality

in children undergoing CPB. In addition to commonly known risk factors, perioperative use of milrinone, particularly in young infants, and furosemide were independently predictive of poor renal outcomes in this sample. Findings suggest a need for the development of protocols aimed at renal protection in specific at risk patients.”
“Nanocrystalline Y0.5Sm0.5Co5 ribbons were obtained by melt spinning using a copper wheel surface speed of 40 m/s. X-ray diffraction patterns from the as-cast ground alloy and from the melt-spun ribbons were indexed as CaCu5-like hexagonal structure. Crystallographic texture was observed and a dendritic microstructure with a AICAR mw dendrite size between 1 and 5 mu m from the noncontacting ribbon surface was measured. In addition, a finer microstructure on the contacting surface was observed. Magnetic measurements, corrected for the demagnetizing field, show a nonsaturated magnetization curve. An initial magnetization curve typical of a nucleation-type magnetization mechanism was observed and an intrinsic coercivity of 1.2 T and a M-r/M-s ratio equal to 0.67 were measured. (C) 2009 American Institute of Physics. [DOI: 10.1063/1.3076139]“
“A universal coagulation test that reliably detects prolonged coagulation time in patients, irrespective of the anticoagulant

Bindarit concentration administered, has not been available to date. An easily miniaturised, novel mu-fluidic universal coagulation test employing surface acoustic waves (SAW) is presented here. SAW was employed to instantly mix and recalcify 6 mu l citrated whole blood and image correlation analysis was used to quantify clot formation kinetics. The detection of clinically relevant anticoagulant dosing with old anticoagulants (unfractionated heparin, argatroban) and new anticoagulants (dabigatran, rivaroxaban) has been tested and compared to standard plasma coagulation assays. The applicability of this novel method has been confirmed in a small patient population. Coagulation was dose-proportionally prolonged with heparin, argatroban, dabigatran, and rivaroxaban, comparable to standard tests.